Filgrastim Completed Phase 1 Trials for Multiple Myeloma and Plasma Cell Neoplasm / Small Intestine Cancer / Chronic Myeloproliferative Disorders / Graft Versus Host Disease (GVHD) / Myelodysplastic Syndromes (MDS) / Precancerous/Nonmalignant Condition / Malignant Lymphomas / Leukemias Treatment